Cost-Effectiveness of Adding Novel or Group 5 Interventions To A Background Regimen For The Treatment of Multidrug-Resistant Tuberculosis In Germany
Abstract
Authors
D Wirth R Dass R Hettle
D Wirth R Dass R Hettle
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now